Literature DB >> 22266188

Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer.

Tetsushi Yamamoto1, Yoko Matsuda, Kiyoko Kawahara, Toshiyuki Ishiwata, Zenya Naito.   

Abstract

Lumican expression in the stromal tissues of pancreatic ductal adenocarcinoma (PDAC) correlates with tumor invasion, and tends to correlate with poor prognosis. We used gene transfection techniques to examine the biological roles of lumican secreted from PDAC cells. Lumican-transfected PANC-1 cells secreted a 70-kDa lumican protein and had an active ERK pathway. Transfection stimulated PANC-1 cell growth, increased cell adhesion to laminin, inhibited cell invasion, and decreased active matrix metalloproteinase-9. Down-regulation of lumican using siRNA resulted in opposite cell behavior. Thus, the 70-kDa lumican secreted by PDAC cells plays important roles in cell growth and invasion.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266188     DOI: 10.1016/j.canlet.2012.01.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth.

Authors:  X Li; Y Kang; D Roife; Y Lee; M Pratt; M R Perez; B Dai; E J Koay; J B Fleming
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

2.  Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.

Authors:  Xinqun Li; Mark A Truty; Ya'an Kang; Xavier Chopin-Laly; Ran Zhang; David Roife; Deyali Chatterjee; E Lin; Ryan M Thomas; Huamin Wang; Matthew H Katz; Jason B Fleming
Journal:  Clin Cancer Res       Date:  2014-10-21       Impact factor: 12.531

3.  Increased Sushi repeat-containing protein X-linked 2 is associated with progression of colorectal cancer.

Authors:  K L Liu; J Wu; Y Zhou; J H Fan
Journal:  Med Oncol       Date:  2015-03-04       Impact factor: 3.064

4.  Lumican exhibits anti-angiogenic activity in a context specific manner.

Authors:  Bikram Sharma; Megan D Ramus; Christopher T Kirkwood; Emma E Sperry; Pao-Hsien Chu; Winston W Kao; Allan R Albig
Journal:  Cancer Microenviron       Date:  2013-06-18

5.  Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.

Authors:  Suzanne Miyamoto; L Renee Ruhaak; Carol Stroble; Michelle R Salemi; Brett Phinney; Carlito B Lebrilla; Gary S Leiserowitz
Journal:  J Proteome Res       Date:  2016-08-23       Impact factor: 4.466

6.  Antitumor efficacy of α-solanine against pancreatic cancer in vitro and in vivo.

Authors:  Chongqing Lv; Hongru Kong; Guohua Dong; Lewei Liu; Kun Tong; Hongwei Sun; Bicheng Chen; Chunwu Zhang; Mengtao Zhou
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

7.  The significance of lumican expression in ovarian cancer drug-resistant cell lines.

Authors:  Andrzej Klejewski; Karolina Sterzyńska; Karolina Wojtowicz; Monika Świerczewska; Małgorzata Partyka; Maciej Brązert; Michał Nowicki; Maciej Zabel; Radosław Januchowski
Journal:  Oncotarget       Date:  2017-08-10

8.  Lumican expression in gastric cancer and its association with biological behavior and prognosis.

Authors:  Li Chen; Yuxin Zhang; Yanjiao Zuo; Fei Ma; Hongjiang Song
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

9.  Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.

Authors:  Cristiano Farace; Jaime Antonio Oliver; Consolacion Melguizo; Pablo Alvarez; Pasquale Bandiera; Ana Rosa Rama; Giulia Malaguarnera; Raul Ortiz; Roberto Madeddu; Jose Prados
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Lumican binds ALK5 to promote epithelium wound healing.

Authors:  Osamu Yamanaka; Yong Yuan; Vivien Jane Coulson-Thomas; Tarsis Ferreira Gesteira; Mindy K Call; Yujin Zhang; Jianhua Zhang; Shao-Hsuan Chang; Changchun Xie; Chia-Yang Liu; Shizuya Saika; James V Jester; Winston W-Y Kao
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.